SERPINA1 and alpha 1-antitrypsin deficiency: According to previous reports, preparations of AAT, which are used to treat emphysema patients with inherited AAT deficiency, can also lower IL-1β-related tissue damage by up-regulating IL-1 receptor antagonist, (Lewis et al., 2008; Abecassis et al., 2014).